Overview

A Study to Explore the Pharmacokinetics of Rilpivirine With Rifabutin in Healthy Participants

Status:
Completed
Trial end date:
2012-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to explore the pharmacokinetics of different dosing regimens of rilpivirine in combination with rifabutin in healthy participants.
Phase:
Phase 1
Details
Lead Sponsor:
Janssen R&D Ireland
Treatments:
Rifabutin
Rilpivirine